These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22172509)

  • 21. Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine.
    Little SF; Ivins BE; Webster WM; Norris SL; Andrews GP
    Vaccine; 2007 Apr; 25(15):2771-7. PubMed ID: 17240008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge.
    Klas SD; Petrie CR; Warwood SJ; Williams MS; Olds CL; Stenz JP; Cheff AM; Hinchcliffe M; Richardson C; Wimer S
    Vaccine; 2008 Oct; 26(43):5494-502. PubMed ID: 18703110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress and novel strategies in vaccine development and treatment of anthrax.
    Chitlaru T; Altboum Z; Reuveny S; Shafferman A
    Immunol Rev; 2011 Jan; 239(1):221-36. PubMed ID: 21198675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.
    Grunow R; Porsch-Ozcürümez M; Splettstoesser W; Buckendahl A; Hahn U; Beyer W; Böhm R; Huber M; vd Esche U; Bessler W; Frangoulidis D; Finke EJ
    Vaccine; 2007 May; 25(18):3679-83. PubMed ID: 17287051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits.
    Ribot WJ; Powell BS; Ivins BE; Little SF; Johnson WM; Hoover TA; Norris SL; Adamovicz JJ; Friedlander AM; Andrews GP
    Vaccine; 2006 Apr; 24(17):3469-76. PubMed ID: 16519970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques.
    Livingston BD; Little SF; Luxembourg A; Ellefsen B; Hannaman D
    Vaccine; 2010 Jan; 28(4):1056-61. PubMed ID: 19896452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.
    Oscherwitz J; Feldman D; Yu F; Cease KB
    Vaccine; 2015 Jan; 33(3):430-6. PubMed ID: 25454087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic immunization against anthrax.
    Galloway D; Liner A; Legutki J; Mateczun A; Barnewall R; Estep J
    Vaccine; 2004 Apr; 22(13-14):1604-8. PubMed ID: 15068841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-wall preparation containing poly-γ-D-glutamate covalently linked to peptidoglycan, a straightforward extractable molecule, protects mice against experimental anthrax infection.
    Candela T; Dumetz F; Tosi-Couture E; Mock M; Goossens PL; Fouet A
    Vaccine; 2012 Dec; 31(1):171-5. PubMed ID: 23122993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S-layer homology motif is an immunogen and confers protection to mouse model against anthrax.
    Kulshreshtha P; Aggarwal S; Jaiswal H; Bhatnagar R
    Mol Immunol; 2012 Feb; 50(1-2):18-25. PubMed ID: 22178119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular basis for improved anthrax vaccines.
    Brey RN
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1266-92. PubMed ID: 15935874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.
    Zhang Y; Qiu J; Zhou Y; Farhangfar F; Hester J; Lin AY; Decker WK
    Vaccine; 2008 Jan; 26(5):614-22. PubMed ID: 18166249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro correlate of immunity in a rabbit model of inhalational anthrax.
    Pitt ML; Little SF; Ivins BE; Fellows P; Barth J; Hewetson J; Gibbs P; Dertzbaugh M; Friedlander AM
    Vaccine; 2001 Sep; 19(32):4768-73. PubMed ID: 11535328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Selected research problems of anthrax vaccine development].
    Zakowska D; Kocik J; Bartoszcze M
    Przegl Epidemiol; 2009; 63(4):505-12. PubMed ID: 20120948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
    Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
    Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens.
    Chua J; Chabot DJ; Putmon-Taylor T; Friedlander AM
    J Vis Exp; 2020 May; (159):. PubMed ID: 32510489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization.
    Herrmann JE; Wang S; Zhang C; Panchal RG; Bavari S; Lyons CR; Lovchik JA; Golding B; Shiloach J; Lu S
    Vaccine; 2006 Jul; 24(31-32):5872-80. PubMed ID: 16790303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG.
    Semenova VA; Schiffer J; Steward-Clark E; Soroka S; Schmidt DS; Brawner MM; Lyde F; Thompson R; Brown N; Foster L; Fox S; Patel N; Freeman AE; Quinn CP
    J Immunol Methods; 2012 Feb; 376(1-2):97-107. PubMed ID: 22197974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism.
    Bouzianas DG
    Expert Rev Anti Infect Ther; 2007 Aug; 5(4):665-84. PubMed ID: 17678429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progress on the vaccine for anthrax].
    Zhan DW; Wang P; Wang LC; Zhang ZS
    Wei Sheng Wu Xue Bao; 2005 Feb; 45(1):149-52. PubMed ID: 15847185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.